Matrix Metalloproteinase Inhibitors Based on the 3-Mercaptopyrrolidine Core
- 30 April 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 56 (11) , 4357-4373
Abstract
New series of pyrrolidine mercaptosulfide, 2-mercaptocyclopentane arylsulfonamide, and 3-mercapto-4-arylsulfonamidopyrrolidine matrix metalloproteinase inhibitors (MMPIs) were designed, synthesized, and evaluated. Exhibiting unique properties over other MMPIs (e.g., hydroxamates), these newly reported compounds are capable of modulating activities of several MMPs in the low nanomolar range, including MMP-2 (∼2 to 50 nM), MMP-13 (∼2 to 50 nM), and MMP-14 (∼4 to 60 nM). Additionally these compounds are selective to intermediate- and deep-pocket MMPs but not shallow-pocketed MMPs (e.g., MMP-1, ∼850 to >50 000 nM; MMP-7, ∼4000 to >25 000 nM). Our previous work with the mercaptosulfide functionality attached to both cyclopentane and pyrrolidine frameworks demonstrated that the cis-(3S,4R)-stereochemistry was optimal for all of the MMPs tested. However, in our newest compounds an interesting shift of preference to the trans form of the mercaptosulfonamides was observed with increased oxidative stability and biological compatibility. We also report several kinetic and biological characteristics showing that these compounds may be used to probe the mechanistic activities of MMPs in disease.Keywords
This publication has 66 references indexed in Scilit:
- Histone Deacetylase (HDAC) Inhibitors with a Novel Connecting Unit Linker Region Reveal a Selectivity Profile for HDAC4 and HDAC5 with Improved Activity against Chemoresistant Cancer CellsJournal of Medicinal Chemistry, 2012
- Matrix metalloproteinases and epidermal wound repairCell and tissue research, 2012
- Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional InhibitorsJournal of Medicinal Chemistry, 2012
- In Vivo PET Imaging of Histone Deacetylases by 18F-Suberoylanilide Hydroxamic Acid (18F-SAHA)Journal of Medicinal Chemistry, 2011
- MMP-13 selective isonipecotamide α-sulfone hydroxamatesBioorganic & Medicinal Chemistry Letters, 2010
- MT1-MMP controls human mesenchymal stem cell trafficking and differentiationBlood, 2010
- Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemiaNeuroscience, 2009
- MMP-1 serum levels predict coronary atherosclerosis in humansCardiovascular Diabetology, 2009
- New Thiol and Sulfodiimine Metalloproteinase Inhibitors and Their Effect on Human Microvascular Endothelial Cell GrowthBiochemical and Biophysical Research Communications, 2000
- Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular DiseasesClinical Pharmacokinetics, 1988